Diabetes Vaccine Market Global Analysis by 2019 to 2026 | By Industry Growth Rate, Size, Share, Current & Future Business Opportunities

Diabetes is a medical condition where the level of sugar in the blood is too high and is one of the most prevalent chronic diseases around the globe. According to WHO (World Health Organization), diabetes was one of the top three leading causes of mortality in 2012. Currently, the diabetes vaccine is under development process which has great potential in younger age population (Below 20 years age), who have a strong autoimmune response to fight against infection from specific viruses. Diabetes vaccine is developed to strengthen the body’s response to enterovirus which is called as coxsackievirus B1, it senses enterovirus and secretes immune response to kill it. Therefore, it kills the insulin produced by the beta cell in the pancreas, which is associated with type 1 diabetes disease. Although, there is no approved diabetes vaccine available in the market, however major players are focusing on increasing more research to produce such vaccines by targeting different process that stimulates the autoimmune response.

Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/1367

Rising prevalence of type 1 diabetes is projected to support the market growth of diabetes vaccine over the forecast timeline

Increasing global prevalence and incidence of type 1 diabetes is, predominantly expected to create a lucrative growth opportunity for market growth of the diabetes vaccine According to the International Diabetes Federation’s (IDF) Diabetes Atlas 2017, around 425 million patients are suffering from diabetes worldwide by the end of 2017. Of this, one million people (children and adolescents below 20 years of age) are suffering from type 1 diabetes, with around 150,000 new cases reported each year.

Moreover, patients with type 1 diabetes require regular monitoring and also require insulin externally, which is administered intramuscularly every day this can be scary for children. Also, the cost associated with insulin therapy is much high, which is further projected to encourage market growth.

LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 25% OFF On Any Research Report
Apply Promo Code “CHRISTMAS2020” And Get Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1367

Market Segmentation

By age group

• Up to 20 years of age
• Above 20 years of age

By End-user

• Hospitals
• Clinics
• Others

North America market is presumed to gain high growth, followed by Europe and Asia Pacific markets over the forecast timeline

North America is projected to experience high growth in the global diabetes vaccine market over the forecast timeline and this can be attributed to rising incidence of diabetes and high investment in healthcare infrastructure in the U.S. For instance, according to IDF, 17,100 new cases were detected in 2017 in the U.S. Around US$ 377 billion was spent over entire diabetes disease range, which accounts for about 52% of the total healthcare expenditure on diabetes worldwide. A significant part of which goes into maintaining constant blood sugar in type 1 by the use of insulin. According to statistics released by the American Diabetes Association, in 2017, around 193,000 people under 20 years of age in the U.S. were estimated to be diagnosed with diabetes, which accounts for 0.24% of this population. This inadvertently is projected to offer room for a growth opportunity to the market.  U.S. has the maximum number of children and adolescent (under age 20) with Type 1 diabetes at a range of 1,69,600 in 2017, this is followed by  India with the highest cases type 1 diabetes after the U.S at a range of 1,28,500 as reported by IDF.

Have a Look at Related Research Insights:

DIABETES DEVICES AND DRUGS (DIAGNOSIS, MONITORING, AND THERAPEUTICS) MARKET ANALYSIS

DIABETES NUTRITION MARKET ANALYSIS

FOOT & ANKLE DEVICES MARKET ANALYSIS

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.